{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:54:24Z","timestamp":1791572064588,"version":"4.3.4"},"reference-count":227,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007793","name":"Stiftelsen Kristian Gerhard Jebsen","doi-asserted-by":"publisher","award":["SKJ-MED-02"],"award-info":[{"award-number":["SKJ-MED-02"]}],"id":[{"id":"10.13039\/100007793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010970","name":"Chiropractic and Osteopathic College of Australasia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010970","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","award":["667302"],"award-info":[{"award-number":["667302"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004257","name":"Helse Vest RHF","doi-asserted-by":"publisher","award":["25048"],"award-info":[{"award-number":["25048"]}],"id":[{"id":"10.13039\/501100004257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005029","name":"Helse Vest Regionalt Helsef\u00f8retak","doi-asserted-by":"publisher","award":["51379"],"award-info":[{"award-number":["51379"]}],"id":[{"id":"10.13039\/501100005029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005029","name":"Helse Vest Regionalt Helsef\u00f8retak","doi-asserted-by":"publisher","award":["815138"],"award-info":[{"award-number":["815138"]}],"id":[{"id":"10.13039\/501100005029","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience & Biobehavioral Reviews"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.neubiorev.2021.11.012","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T15:50:09Z","timestamp":1636645809000},"page":"838-856","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["ADHD symptoms in neurometabolic diseases: Underlying mechanisms and clinical implications"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1202-7692","authenticated-orcid":false,"given":"Selina","family":"Cannon Homaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9600-3219","authenticated-orcid":false,"given":"Helene","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6086-755X","authenticated-orcid":false,"given":"Rune","family":"Kleppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9577-4284","authenticated-orcid":false,"given":"Nibal","family":"Betari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0992-634X","authenticated-orcid":false,"given":"Andreas","family":"Reif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7865-2808","authenticated-orcid":false,"given":"Jan","family":"Haavik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2021.11.012_bib0005","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/ajmg.1320260427","article-title":"Psychiatric manifestations of homocystinuria due to cystathionine beta-synthase deficiency: prevalence, natural history, and relationship to neurologic impairment and vitamin B6-responsiveness","volume":"26","author":"Abbott","year":"1987","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0010","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s10545-017-0083-x","article-title":"Long-term metabolic follow-up and clinical outcome of 35 patients with maple syrup urine disease","volume":"40","author":"Abi-Warde","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6","key":"10.1016\/j.neubiorev.2021.11.012_bib0015","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/jimd.12413","article-title":"Long-term cognitive and psychosocial outcomes in adults with phenylketonuria","volume":"44","author":"Aitkenhead","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1432-1033.1992.tb17283.x","article-title":"Regulation of recombinant human tyrosine hydroxylase isozymes by catecholamine binding and phosphorylation. Structure\/activity studies and mechanistic implications","volume":"209","author":"Almas","year":"1992","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0025","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1021\/cn300154j","article-title":"Life without peripheral serotonin: insights from tryptophan hydroxylase 1 knockout mice reveal the existence of paracrine\/autocrine serotonergic networks","volume":"4","author":"Amireault","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0030","doi-asserted-by":"crossref","first-page":"18621","DOI":"10.1016\/S0021-9258(18)37330-7","article-title":"Resonance Raman studies on the blue-green-colored bovine adrenal tyrosine 3-monooxygenase (tyrosine hydroxylase). Evidence that the feedback inhibitors adrenaline and noradrenaline are coordinated to iron","volume":"263","author":"Andersson","year":"1988","journal-title":"J. Biol. Chem."},{"issue":"Pt 3","key":"10.1016\/j.neubiorev.2021.11.012_bib0035","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1042\/bj2840687","article-title":"Purification and characterization of the blue-green rat phaeochromocytoma (PC12) tyrosine hydroxylase with a dopamine-Fe(III) complex. Reversal of the endogenous feedback inhibition by phosphorylation of serine-40","volume":"284","author":"Andersson","year":"1992","journal-title":"Biochem. J."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0040","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/ped.12636","article-title":"Sanfilippo syndrome: overall review","volume":"57","author":"Andrade","year":"2015","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0045","doi-asserted-by":"crossref","first-page":"506","DOI":"10.4088\/JCP.11r07237","article-title":"The psychiatric manifestations of mitochondrial disorders: a case and review of the literature","volume":"73","author":"Anglin","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0050","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/BF01799945","article-title":"Content of phenylalanine, tyrosine and their metabolites in CSF in phenylketonuria","volume":"14","author":"Antoshechkin","year":"1991","journal-title":"J. Inherit. Metab. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.neubiorev.2021.11.012_bib0055","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.ymgme.2009.09.013","article-title":"ADHD, learning, and academic performance in phenylketonuria","volume":"99","author":"Antshel","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0060","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1023\/A:1026239921561","article-title":"Developmental timing of exposure to elevated levels of phenylalanine is associated with ADHD symptom expression","volume":"31","author":"Antshel","year":"2003","journal-title":"J. Abnorm. Child Psychol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0065","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1023\/A:1025071014191","article-title":"Plasma amino acids profiles in children with autism: potential risk of nutritional deficiencies","volume":"33","author":"Arnold","year":"2003","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0070","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1023\/B:BOLI.0000028725.37345.62","article-title":"Prevalence of stimulant use for attentional dysfunction in children with phenylketonuria","volume":"27","author":"Arnold","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0075","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/jcpp.12864","article-title":"Secular changes in the symptom level of clinically diagnosed autism","volume":"59","author":"Arvidsson","year":"2018","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0080","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3389\/fpsyt.2019.00561","article-title":"Psychiatric and cognitive aspects of phenylketonuria: the limitations of diet and promise of new treatments","volume":"10","author":"Ashe","year":"2019","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0085","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/arclin\/acq014","article-title":"Impairment in occupational functioning and adult ADHD: the predictive utility of executive function (EF) ratings versus EF tests","volume":"25","author":"Barkley","year":"2010","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0090","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ajmg.b.32764","article-title":"Tyrosinemia Type 1 and symptoms of ADHD: biochemical mechanisms and implications for treatment and prognosis","volume":"183","author":"Barone","year":"2020","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0095","doi-asserted-by":"crossref","DOI":"10.1590\/1984-0462\/2020\/38\/2018158","article-title":"Tyrosinemia type Iii: a case report of siblings and literature review","volume":"38","author":"Barroso","year":"2020","journal-title":"Rev. Paul. Pediatr."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/adc.73.1.77","article-title":"Behaviour in mucopolysaccharide disorders","volume":"73","author":"Bax","year":"1995","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0105","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S1096-7192(02)00172-5","article-title":"Variable clinical presentation of lysosomal beta-mannosidosis in patients with null mutations","volume":"77","author":"Bedilu","year":"2002","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0110","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/jcbfm.2012.115","article-title":"The locus coeruleus-norepinephrine network optimizes coupling of cerebral blood volume with oxygen demand","volume":"32","author":"Bekar","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0115","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ymgme.2019.08.004","article-title":"Of mice and men: plasma phenylalanine reduction in PKU corrects neurotransmitter pathways in the brain","volume":"128","author":"Berguig","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0120","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41416-019-0659-3","article-title":"Kinetic modelling of quantitative proteome data predicts metabolic reprogramming of liver cancer","volume":"122","author":"Berndt","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0125","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1469-8749.1979.tb01623.x","article-title":"Intellectual development and academic achievement of children treated early for phenylketonuria","volume":"21","author":"Berry","year":"1979","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0130","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0014-2999(99)00515-4","article-title":"Gamma-Hydroxybutyrate inhibits excitatory postsynaptic potentials in rat hippocampal slices","volume":"380","author":"Berton","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1742-4682-6-21","article-title":"Homeostatic mechanisms in dopamine synthesis and release: a mathematical model","volume":"6","author":"Best","year":"2009","journal-title":"Theor. Biol. Med. Model."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0140","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1176\/ajp.2006.163.10.1730","article-title":"Impact of psychometrically defined deficits of executive functioning in adults with attention deficit hyperactivity disorder","volume":"163","author":"Biederman","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2017.03.002","article-title":"Neuropsychiatric comorbidities in adults with phenylketonuria: a retrospective cohort study","volume":"121","author":"Bilder","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0150","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/02643294.2018.1443913","article-title":"Markers of cognitive function in individuals with metabolic disease: morquio syndrome and tyrosinemia type III","volume":"35","author":"Blundell","year":"2018","journal-title":"Cogn. Neuropsychol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/B978-0-12-386467-3.00002-9","article-title":"Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence","volume":"100","author":"Bortolato","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0160","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/ajmg.b.30873","article-title":"Association of the steroid sulfatase (STS) gene with attention deficit hyperactivity disorder","volume":"147B","author":"Brookes","year":"2008","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0165","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nbt.4072","article-title":"Recon3D enables a three-dimensional view of gene variation in human metabolism","volume":"36","author":"Brunk","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0170","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1126\/science.8211186","article-title":"Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A","volume":"262","author":"Brunner","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0175","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ymgme.2014.11.011","article-title":"A randomized, placebo-controlled, double-blind study of sapropterin to treat ADHD symptoms and executive function impairment in children and adults with sapropterin-responsive phenylketonuria","volume":"114","author":"Burton","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0180","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/j.ejrad.2009.05.048","article-title":"Diagnostic value of proton MR spectroscopy and diffusion-weighted MR imaging in childhood inherited neurometabolic brain diseases and review of the literature","volume":"74","author":"Cakmakci","year":"2010","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0185","doi-asserted-by":"crossref","first-page":"e1036","DOI":"10.1002\/mgg3.1036","article-title":"Abnormalities in the genes that encode large amino acid transporters increase the risk of autism spectrum disorder","volume":"8","author":"Cascio","year":"2020","journal-title":"Mol. Genet. Genomic Med."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0190","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.euroneuro.2011.04.003","article-title":"Methylphenidate administration determines enduring changes in neuroglial network in rats","volume":"22","author":"Cavaliere","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0195","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1651-2227.1997.tb15192.x","article-title":"Tyrosinemia type III: diagnosis and ten-year follow-up","volume":"86","author":"Cerone","year":"1997","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164417","article-title":"Behavioural and psychiatric phenotypes in men and boys with X-linked ichthyosis: evidence from a worldwide online survey","volume":"11","author":"Chatterjee","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0205","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3109\/02699052.2012.666366","article-title":"Ecological assessment of cognitive functions in children with acquired brain injury: a systematic review","volume":"26","author":"Chevignard","year":"2012","journal-title":"Brain Inj."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0210","doi-asserted-by":"crossref","first-page":"19198","DOI":"10.1074\/jbc.M908734199","article-title":"The mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode syndrome-associated human mitochondrial tRNALeu(UUR) mutation causes aminoacylation deficiency and concomitant reduced association of mRNA with ribosomes","volume":"275","author":"Chomyn","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0215","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3389\/fnmol.2017.00318","article-title":"14-3-3 proteins in brain development: neurogenesis, neuronal migration and neuromorphogenesis","volume":"10","author":"Cornell","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0220","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11920-017-0754-1","article-title":"Attention-Deficit\/Hyperactivity Disorder (ADHD) and obesity: update 2016","volume":"19","author":"Cortese","year":"2017","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0225","doi-asserted-by":"crossref","first-page":"13525","DOI":"10.1073\/pnas.2233056100","article-title":"Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function","volume":"100","author":"Cote","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0230","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1073\/pnas.0606722104","article-title":"Maternal serotonin is crucial for murine embryonic development","volume":"104","author":"Cote","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0235","doi-asserted-by":"crossref","first-page":"28128","DOI":"10.1074\/jbc.M109.041483","article-title":"Critical role for tetrahydrobiopterin recycling by dihydrofolate reductase in regulation of endothelial nitric-oxide synthase coupling: relative importance of the de novo biopterin synthesis versus salvage pathways","volume":"284","author":"Crabtree","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0240","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nm.3766","article-title":"Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis","volume":"21","author":"Crane","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0245","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ymgme.2018.07.008","article-title":"Clinical and biochemical assessment of depressive symptoms in patients with Alkaptonuria before and after two years of treatment with nitisinone","volume":"125","author":"Davison","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0250","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11306-019-1531-4","article-title":"Assessing the effect of nitisinone induced hypertyrosinaemia on monoamine neurotransmitters in brain tissue from a murine model of alkaptonuria using mass spectrometry imaging","volume":"15","author":"Davison","year":"2019","journal-title":"Metabolomics"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0255","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.bbadis.2013.02.001","article-title":"Branched-chain amino acids influence the immune properties of microglial cells and their responsiveness to pro-inflammatory signals","volume":"1832","author":"De Simone","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0260","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41588-018-0269-7","article-title":"Discovery of the first genome-wide significant risk loci for attention deficit\/hyperactivity disorder","volume":"51","author":"Demontis","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0265","doi-asserted-by":"crossref","DOI":"10.2307\/1166208","article-title":"Prefrontal cortex cognitive deficits in children treated early and continuously for PKU","volume":"62","author":"Diamond","year":"1997","journal-title":"Monogr. Soc. Res. Child Dev."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0270","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/acn3.696","article-title":"Age-related phenotype and biomarker changes in SSADH deficiency","volume":"6","author":"DiBacco","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0275","first-page":"9","article-title":"Succinic semialdehyde dehydrogenase deficiency: an update","author":"Didiasova","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0280","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1212\/01.WNL.0000156800.23776.40","article-title":"Glycine decarboxylase mutations: a distinctive phenotype of nonketotic hyperglycinemia in adults","volume":"64","author":"Dinopoulos","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0285","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/exd.13667","article-title":"X-linked ichthyosis: clinical and molecular findings in 35 Italian patients","volume":"28","author":"Diociaiuti","year":"2019","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0290","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1542\/peds.58.1.53","article-title":"Intellectual performance of 36 phenylketonuria patients and their nonaffected siblings","volume":"58","author":"Dobson","year":"1976","journal-title":"Pediatrics"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0295","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12987-020-0178-x","article-title":"Choroid plexus LAT2 and SNAT3 as partners in CSF amino acid homeostasis maintenance","volume":"17","author":"Dolgodilina","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0300","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.neurol.2018.07.002","article-title":"Monoamine neurotransmitters and movement disorders in children and adults","volume":"174","author":"Doummar","year":"2018","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0305","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/jnc.14675","article-title":"Tyrosine hydroxylase phosphorylation in vivo","volume":"149","author":"Dunkley","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0310","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-981-10-7757-9_5","article-title":"Monoamine oxidases","volume":"87","author":"Edmondson","year":"2018","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0315","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ymgme.2012.01.016","article-title":"Restoration of impaired nitric oxide production in MELAS syndrome with citrulline and arginine supplementation","volume":"105","author":"El-Hattab","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0320","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.biocel.2013.12.009","article-title":"Mitochondria: role of citrulline and arginine supplementation in MELAS syndrome","volume":"48","author":"El-Hattab","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0325","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2015.06.004","article-title":"MELAS syndrome: clinical manifestations, pathogenesis, and treatment options","volume":"116","author":"El-Hattab","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0330","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1523-1747.2003.22258.x","article-title":"Basis for abnormal desquamation and permeability barrier dysfunction in RXLI","volume":"122","author":"Elias","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0335","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1023\/A:1013936107064","article-title":"Outcome of tyrosinaemia type III","volume":"24","author":"Ellaway","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0340","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0190-9622(84)80144-9","article-title":"The epidermal cholesterol sulfate cycle","volume":"10","author":"Epstein","year":"1984","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0345","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1179\/147683008X301360","article-title":"Altered amino acid excretion in children with autism","volume":"11","author":"Evans","year":"2008","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0350","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/jimd.12151","article-title":"Tetrahydrobiopterin treatment in phenylketonuria: a repurposing approach","volume":"43","author":"Evers","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0355","doi-asserted-by":"crossref","first-page":"15020","DOI":"10.1038\/nrdp.2015.20","article-title":"Attention-deficit\/hyperactivity disorder","volume":"1","author":"Faraone","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0360","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2020.588954","article-title":"The creatine transporter unfolded: a knotty premise in the cerebral creatine deficiency syndrome","volume":"12","author":"Farr","year":"2020","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0365","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1128\/MCB.22.13.4943-4951.2002","article-title":"Maleylacetoacetate isomerase (MAAI\/GSTZ)-deficient mice reveal a glutathione-dependent nonenzymatic bypass in tyrosine catabolism","volume":"22","author":"Fernandez-Canon","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0370","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3389\/fphar.2016.00340","article-title":"Inhibitors of MAO-A and MAO-B in psychiatry and neurology","volume":"7","author":"Finberg","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0375","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/iub.1150","article-title":"Phenylalanine hydroxylase: function, structure, and regulation","volume":"65","author":"Flydal","year":"2013","journal-title":"IUBMB Life"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0380","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/humu.22565","article-title":"Functional studies of tyrosine hydroxylase missense variants reveal distinct patterns of molecular defects in Dopa-responsive dystonia","volume":"35","author":"Fossbakk","year":"2014","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0385","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1038\/tp.2013.76","article-title":"Psychiatric manifestations in cerebrotendinous xanthomatosis","volume":"3","author":"Fraidakis","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0390","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1021\/bi052283j","article-title":"Reduction and oxidation of the active site iron in tyrosine hydroxylase: kinetics and specificity","volume":"45","author":"Frantom","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0395","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ymgme.2014.05.006","article-title":"Nutrition management guideline for maple syrup urine disease: an evidence- and consensus-based approach","volume":"112","author":"Frazier","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0400","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/gbb.12193","article-title":"Neuronal nitric oxide synthase (NOS1) and its adaptor, NOS1AP, as a genetic risk factors for psychiatric disorders","volume":"14","author":"Freudenberg","year":"2015","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0405","first-page":"12","article-title":"Long-term cognitive functioning in individuals with tyrosinemia type 1 treated with nitisinone and protein-restricted diet","volume":"11","author":"Garcia","year":"2017","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0410","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/humu.22513","article-title":"Two novel mutations in the BCKDK (branched-chain keto-acid dehydrogenase kinase) gene are responsible for a neurobehavioral deficit in two pediatric unrelated patients","volume":"35","author":"Garcia-Cazorla","year":"2014","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0415","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s00726-015-2157-0","article-title":"Regulation of tyrosine hydroxylase is preserved across different homo- and heterodimeric 14-3-3 proteins","volume":"48","author":"Ghorbani","year":"2016","journal-title":"Amino Acids"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0420","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"2079","article-title":"Disorders of beta- and gamma-amino acids in free and peptide-linked forms","author":"Gibson","year":"2001"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0425","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1542\/peds.99.4.567","article-title":"The clinical phenotype of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria): case reports of 23 new patients","volume":"99","author":"Gibson","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0430","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0006-3223(03)00113-6","article-title":"Significant behavioral disturbances in succinic semialdehyde dehydrogenase (SSADH) deficiency (gamma-hydroxybutyric aciduria)","volume":"54","author":"Gibson","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0435","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/ped.13062","article-title":"Tyrosinemia type II: novel mutations in TAT in a boy with unusual presentation","volume":"58","author":"Gokay","year":"2016","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0440","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0140-6736(64)92853-3","article-title":"Fibrosis in the carcinoid syndrome","volume":"1","author":"Hallen","year":"1964","journal-title":"Lancet"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0445","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/archgenpsychiatry.2010.124","article-title":"Attention-deficit\/hyperactivity disorder symptoms in offspring of mothers with impaired serotonin production","volume":"67","author":"Halmoy","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0450","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1172\/JCI73778","article-title":"Missense dopamine transporter mutations associate with adult parkinsonism and ADHD","volume":"124","author":"Hansen","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0455","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s10545-013-9675-2","article-title":"Pharmacologic inhibition of L-tyrosine degradation ameliorates cerebral dopamine deficiency in murine phenylketonuria (PKU)","volume":"37","author":"Harding","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0460","doi-asserted-by":"crossref","first-page":"218S","DOI":"10.1093\/jn\/136.1.218S","article-title":"Structure of the blood-brain barrier and its role in the transport of amino acids","volume":"136","author":"Hawkins","year":"2006","journal-title":"J. Nutr."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0465","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4161\/gmic.22370","article-title":"Systems-level characterization of a host-microbe metabolic symbiosis in the mammalian gut","volume":"4","author":"Heinken","year":"2013","journal-title":"Gut Microbes"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0470","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ejpn.2015.04.004","article-title":"Diagnostic overshadowing in a population of children with neurological disabilities: a cross sectional descriptive study on acquired ADHD","volume":"19","author":"Hendriksen","year":"2015","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0475","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1046\/j.1365-2133.1999.03098.x","article-title":"X-linked ichthyosis: an update","volume":"141","author":"Hernandez-Martin","year":"1999","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0480","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ajmg.a.33779","article-title":"Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece","volume":"155A","author":"Heron","year":"2011","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0485","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ymgme.2012.09.002","article-title":"Tyrosinemia Type III detected via neonatal screening: management and outcome","volume":"107","author":"Heylen","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0490","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s13023-020-01548-9","article-title":"Challenging behavior in mucopolysaccharidoses types I-III and day-to-day coping strategies: a cross sectional explorative study","volume":"15","author":"Hoffmann","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0495","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1515\/hsz-2019-0386","article-title":"The cGMP system: components and function","volume":"401","author":"Hofmann","year":"2020","journal-title":"Biol. Chem."},{"issue":"Suppl","key":"10.1016\/j.neubiorev.2021.11.012_bib0500","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.ymgme.2013.10.001","article-title":"Executive functioning in context: relevance for treatment and monitoring of phenylketonuria","volume":"110","author":"Huijbregts","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0505","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1002\/jbmr.439","article-title":"Efficacy of serotonin inhibition in mouse models of bone loss","volume":"26","author":"Inose","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0510","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/1087054716669589","article-title":"Adult ADHD and comorbid somatic disease: a systematic literature review","volume":"22","author":"Instanes","year":"2018","journal-title":"J. Atten. Disord."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0515","doi-asserted-by":"crossref","first-page":"15673","DOI":"10.1021\/bi9914255","article-title":"Stimulus-coupled interaction of tyrosine hydroxylase with 14-3-3 proteins","volume":"38","author":"Itagaki","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0520","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1037\/neu0000103","article-title":"Diverse attention deficits in patients with neurologically symptomatic and asymptomatic Wilson\u2019s disease","volume":"29","author":"Iwanski","year":"2015","journal-title":"Neuropsychology"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0525","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/ajmg.b.32339","article-title":"Epistatic and gene wide effects in YWHA and aromatic amino hydroxylase genes across ADHD and other common neuropsychiatric disorders: association with YWHAE","volume":"168","author":"Jacobsen","year":"2015","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0530","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10545-016-9918-0","article-title":"Social-cognitive functioning and social skills in patients with early treated phenylketonuria: a PKU-COBESO study","volume":"39","author":"Jahja","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0535","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0009-8981(81)90184-4","article-title":"Urinary excretion of gamma-hydroxybutyric acid in a patient with neurological abnormalities. The probability of a new inborn error of metabolism","volume":"111","author":"Jakobs","year":"1981","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0540","first-page":"9","article-title":"Enhanced nitric oxide (NO) and decreased ADMA synthesis in pediatric ADHD and selective potentiation of NO synthesis by methylphenidate","author":"Jansen","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0545","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cell.2014.03.001","article-title":"The molecular and systems biology of memory","volume":"157","author":"Kandel","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0550","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/jmg.2008.057729","article-title":"X-linked ichthyosis (steroid sulfatase deficiency) is associated with increased risk of attention deficit hyperactivity disorder, autism and social communication deficits","volume":"45","author":"Kent","year":"2008","journal-title":"J. Med. Genet."},{"issue":"5","key":"10.1016\/j.neubiorev.2021.11.012_bib0555","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/jimd.12229","article-title":"Nitisinone causes acquired tyrosinosis in alkaptonuria","volume":"43","author":"Khedr","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0560","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.beproc.2019.01.001","article-title":"Models of attention-deficit hyperactivity disorder","volume":"162","author":"Killeen","year":"2019","journal-title":"Behav. Processes"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0565","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.neubiorev.2013.02.011","article-title":"A behavioral neuroenergetics theory of ADHD","volume":"37","author":"Killeen","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2021.104197","article-title":"Alkaptonuria in Turkey: clinical and molecular characteristics of 66 patients","volume":"64","author":"Kisa","year":"2021","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0575","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/0269881114555251","article-title":"Multi-level biomarker analysis of nitric oxide synthase isoforms in bipolar disorder and adult ADHD","volume":"29","author":"Kittel-Schneider","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0580","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neubiorev.2017.01.013","article-title":"Brain imaging genetics in ADHD and beyond - mapping pathways from gene to disorder at different levels of complexity","volume":"80","author":"Klein","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0585","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10545-007-0574-2","volume":"30","author":"Knerr","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0590","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1017\/S1092852900016874","article-title":"Neuropsychiatric morbidity in adolescent and adult succinic semialdehyde dehydrogenase deficiency patients","volume":"13","author":"Knerr","year":"2008","journal-title":"CNS Spectr."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0595","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/BF01805813","article-title":"Paired comparisons between early treated PKU children and their matched sibling controls on intelligence and school achievement test results at eight years of age","volume":"7","author":"Koch","year":"1984","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0600","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s10545-018-0201-4","article-title":"Metabolism of amino acid neurotransmitters: the synaptic disorder underlying inherited metabolic diseases","volume":"41","author":"Kolker","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0605","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1515\/jpem-2019-0505","article-title":"Mucopolysaccharidosis III in Mainland China: natural history, clinical and molecular characteristics of 34 patients","volume":"33","author":"Kong","year":"2020","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0610","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mito.2017.12.012","article-title":"Cognitive impairment, clinical severity and MRI changes in MELAS syndrome","volume":"44","author":"Kraya","year":"2019","journal-title":"Mitochondrion"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0615","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1080\/09297049.2017.1386781","article-title":"Assessment of executive function in ADHD adolescents: contribution of performance tests and rating scales","volume":"24","author":"Krieger","year":"2018","journal-title":"Child Neuropsychol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0620","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1177\/0883073807307078","article-title":"The prevalence of attention-deficit\/hyperactivity disorder among persons with albinism","volume":"22","author":"Kutzbach","year":"2007","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.10.043","article-title":"ASL metabolically regulates tyrosine hydroxylase in the nucleus locus coeruleus","volume":"29","author":"Lerner","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0630","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1046\/j.0953-816x.2000.01443.x","article-title":"Dopamine D(2) receptors regulate tyrosine hydroxylase activity and phosphorylation at Ser40 in rat striatum","volume":"13","author":"Lindgren","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0635","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/BF00441411","article-title":"Increased neurotransmitter biosynthesis in phenylketonuria induced by phenylalanine restriction or by supplementation of unrestricted diet with large amounts of tyrosine","volume":"148","author":"Lykkelund","year":"1988","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0640","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000073626","article-title":"Three-month treatment course of methylphenidate increases plasma levels of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulfate (DHEA-S) in attention deficit hyperactivity disorder","volume":"48","author":"Maayan","year":"2003","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0645","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3181\/00379727-97-23734","article-title":"Dermal fibrosis following subcutaneous injections of serotonin creatinine sulphate","volume":"97","author":"Macdonald","year":"1958","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0650","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.parkreldis.2021.06.011","article-title":"The neurological and neuropsychiatric spectrum of adults with late-treated phenylketonuria","volume":"89","author":"Mainka","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0655","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1460-9568.2005.04264.x","article-title":"Tissue-specific expression of tryptophan hydroxylase mRNAs in the rat midbrain: anatomical evidence and daily profiles","volume":"22","author":"Malek","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0660","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10545-008-0793-1","article-title":"NTBC treatment in tyrosinaemia type I: long-term outcome in French patients","volume":"31","author":"Masurel-Paulet","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0665","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000279322","article-title":"Tryptophan hydroxylase as novel target for the treatment of depressive disorders","volume":"85","author":"Matthes","year":"2010","journal-title":"Pharmacology"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0670","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1073\/pnas.0808376106","article-title":"Monoamine oxidase A gene (MAOA) predicts behavioral aggression following provocation","volume":"106","author":"McDermott","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0675","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1471-4159.2004.02850.x","article-title":"Different properties of the central and peripheral forms of human tryptophan hydroxylase","volume":"92","author":"McKinney","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0680","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/sj.mp.4002152","article-title":"A loss-of-function mutation in tryptophan hydroxylase 2 segregating with attention-deficit\/hyperactivity disorder","volume":"13","author":"McKinney","year":"2008","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2021.11.012_bib0685","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ajmg.c.31933","article-title":"Maple syrup urine disease: characteristics of diagnosis and treatment in 45 patients in Chile","volume":"187","author":"Medina","year":"2021","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0690","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s13238-010-0128-5","article-title":"Tyrosine aminotransferase: biochemical and structural properties and molecular dynamics simulations","volume":"1","author":"Mehere","year":"2010","journal-title":"Protein Cell"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0695","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s11011-015-9686-9","article-title":"Investigation of inflammatory profile in MSUD patients: benefit of L-carnitine supplementation","volume":"30","author":"Mescka","year":"2015","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0700","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"1777","article-title":"Hypertyrosinemia","author":"Mitchell","year":"2001"},{"issue":"5","key":"10.1016\/j.neubiorev.2021.11.012_bib0705","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/YPG.0000000000000294","article-title":"Schizophreniform presentation and abrupt neurologic decline in a patient with late-onset mucopolysaccharidosis type IIIB","volume":"31","author":"Montenegro","year":"2021","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0710","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ene.14068","article-title":"Systematic review of cognitive deficits in adult mitochondrial disease","volume":"27","author":"Moore","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0715","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000252210.58849.78","article-title":"Effect of tryptophan hydroxylase 1 deficiency on the development of hypoxia-induced pulmonary hypertension","volume":"49","author":"Morecroft","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0720","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/s41386-019-0592-4","article-title":"Cross-disorder genetic analyses implicate dopaminergic signaling as a biological link between Attention-Deficit\/Hyperactivity Disorder and obesity measures","volume":"45","author":"Mota","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0725","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1172\/JCI67217","article-title":"Biochemical correlates of neuropsychiatric illness in maple syrup urine disease","volume":"123","author":"Muelly","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0730","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1046\/j.1471-4159.2003.01839.x","article-title":"Oxidation of 4-hydroxy-2-nonenal by succinic semialdehyde dehydrogenase (ALDH5A)","volume":"86","author":"Murphy","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0735","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1523\/JNEUROSCI.1835-05.2006","article-title":"Late developmental stage-specific role of tryptophan hydroxylase 1 in brain serotonin levels","volume":"26","author":"Nakamura","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0740","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/WNN.0b013e3180335faf","article-title":"The neuropsychologic deficits of MELAS: evidence of global impairment","volume":"20","author":"Neargarder","year":"2007","journal-title":"Cogn. Behav. Neurol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0745","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.biopsych.2004.08.025","article-title":"Causal heterogeneity in attention-deficit\/hyperactivity disorder: do we need neuropsychologically impaired subtypes?","volume":"57","author":"Nigg","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0750","doi-asserted-by":"crossref","first-page":"10460","DOI":"10.1523\/JNEUROSCI.2518-08.2008","article-title":"Distinct roles of PDE4 and PDE10A in the regulation of cAMP\/PKA signaling in the striatum","volume":"28","author":"Nishi","year":"2008","journal-title":"J. Neurosci."},{"issue":"Suppl E1","key":"10.1016\/j.neubiorev.2021.11.012_bib0755","first-page":"4","article-title":"Relationship of neurotransmitters to the symptoms of major depressive disorder","volume":"69","author":"Nutt","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0760","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/pedi.12651","article-title":"Previously undiagnosed attention-deficit\/hyperactivity disorder associated with poor metabolic control in adolescents with type 1 diabetes","volume":"19","author":"Nylander","year":"2018","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0765","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0022-3476(68)80320-8","article-title":"Some observations on the dietary treatment of phenylketonuria","volume":"72","author":"O\u2019Flynn","year":"1968","journal-title":"J. Pediatr."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0770","doi-asserted-by":"crossref","first-page":"E1167","DOI":"10.1152\/ajpendo.00193.2003","article-title":"Na+-dependent transport of large neutral amino acids occurs at the abluminal membrane of the blood-brain barrier","volume":"285","author":"O\u2019Kane","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0775","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0040-8166(98)80078-5","article-title":"Immunohistochemical study of localization of gamma-glutamyl transpeptidase in the rat brain","volume":"30","author":"Ogawa","year":"1998","journal-title":"Tissue Cell"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0780","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1097\/00001756-200212200-00036","article-title":"Deficits in brain serotonin synthesis in a genetic mouse model of phenylketonuria","volume":"13","author":"Pascucci","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0785","series-title":"Succinic Semialdehyde Dehydrogenase Deficiency","author":"Pearl","year":"1993"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0790","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1212\/01.WNL.0000059549.70717.80","article-title":"Clinical spectrum of succinic semialdehyde dehydrogenase deficiency","volume":"60","author":"Pearl","year":"2003","journal-title":"Neurology"},{"issue":"Suppl. 6","key":"10.1016\/j.neubiorev.2021.11.012_bib0795","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1002\/ana.10629","article-title":"Succinic semialdehyde dehydrogenase deficiency in children and adults","volume":"54","author":"Pearl","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0800","doi-asserted-by":"crossref","DOI":"10.1177\/0883073820981262","article-title":"Succinic semialdehyde dehydrogenase deficiency: review of the natural history study","author":"Pearl","year":"2021","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0805","first-page":"575","article-title":"Amino compounds and organic acids in CSF, plasma, and urine of autistic children","volume":"13","author":"Perry","year":"1978","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0810","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/jimd.12049","article-title":"Cerebrospinal fluid biogenic amines depletion and brain atrophy in adult patients with phenylketonuria","volume":"42","author":"Pilotto","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0815","first-page":"96","article-title":"Behavioral and intellectual functioning in patients with tyrosinemia type I","volume":"18","author":"Pohorecka","year":"2012","journal-title":"Pediatr. Endocrinol. Diabetes Metab."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0820","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ejpn.2015.01.010","article-title":"Short prolactin profile for monitoring treatment in BH4 deficiency","volume":"19","author":"Porta","year":"2015","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0825","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jad.2007.11.010","article-title":"Tryptophan hydroxylase gene (TPH1) and peripheral tryptophan levels in depression","volume":"109","author":"Porter","year":"2008","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0830","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ymgme.2018.07.011","article-title":"Nitisinone arrests ochronosis and decreases rate of progression of Alkaptonuria: evaluation of the effect of nitisinone in the United Kingdom National Alkaptonuria Centre","volume":"125","author":"Ranganath","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0835","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/bjd.16826","article-title":"Evidence of the high prevalence of neurological disorders in nonsyndromic X-linked recessive ichthyosis: a retrospective case series","volume":"179","author":"Rodrigo-Nicolas","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0840","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1006\/abbi.1999.1199","article-title":"Phosphorylation of tyrosine hydroxylase by cGMP-dependent protein kinase in intact bovine chromaffin cells","volume":"366","author":"Rodriguez-Pascual","year":"1999","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0845","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00726-007-0547-7","article-title":"Oxygen dependence of tyrosine hydroxylase","volume":"34","author":"Rostrup","year":"2008","journal-title":"Amino Acids"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0850","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1038\/s41386-020-0664-5","article-title":"Shared genetic background between children and adults with attention deficit\/hyperactivity disorder","volume":"45","author":"Rovira","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0855","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1744-9081-2-30","article-title":"Response variability in Attention-Deficit\/Hyperactivity Disorder: a neuronal and glial energetics hypothesis","volume":"2","author":"Russell","year":"2006","journal-title":"Behav. Brain Funct."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0860","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s100240010146","article-title":"Tyrosinemia: a review","volume":"4","author":"Russo","year":"2001","journal-title":"Pediatr. Dev. Pathol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0865","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1073\/pnas.1416866112","article-title":"Brain 5-HT deficiency increases stress vulnerability and impairs antidepressant responses following psychosocial stress","volume":"112","author":"Sachs","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0870","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10545-017-0093-8","article-title":"Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX)","volume":"40","author":"Salen","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0875","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1021\/acschemneuro.6b00064","article-title":"Regulation of tyrosine hydroxylase expression and phosphorylation in dopamine transporter-deficient mice","volume":"7","author":"Salvatore","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0880","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s12035-013-8618-0","article-title":"Coadministration of branched-chain amino acids and lipopolysaccharide causes matrix metalloproteinase activation and blood-brain barrier breakdown","volume":"50","author":"Scaini","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0885","first-page":"12","article-title":"Large Neutral Amino Acids (LNAAs) supplementation improves neuropsychological performances in adult patients with phenylketonuria","author":"Scala","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0890","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1212\/01.wnl.0000219759.72195.41","article-title":"Mitochondrial disease in adults: a scale to monitor progression and treatment","volume":"66","author":"Schaefer","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0895","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ajmg.c.30092","article-title":"The genetic tyrosinemias","volume":"142C","author":"Scott","year":"2006","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0900","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/BF00272386","article-title":"Hyperphenylalaninemia due to deficiency of 6-pyruvoyl tetrahydropterin synthase. Unusual gene dosage effect in heterozygotes","volume":"77","author":"Scriver","year":"1987","journal-title":"Hum. Genet."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0905","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.ge.28.120194.001041","article-title":"The hyperphenylalaninemias of man and mouse","volume":"28","author":"Scriver","year":"1994","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0910","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10545-007-0661-4","article-title":"Psychiatric manifestations revealing inborn errors of metabolism in adolescents and adults","volume":"30","author":"Sedel","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0915","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1177\/0883073809340696","article-title":"Neuropsychiatric manifestations in late-onset urea cycle disorder patients","volume":"25","author":"Serrano","year":"2010","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0920","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/jdn.10076","article-title":"Papaverine ameliorates prenatal alcohol-induced experimental attention deficit hyperactivity disorder by regulating neuronal function, inflammation, and oxidative stress","volume":"81","author":"Sharma","year":"2021","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0925","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00787-016-0908-4","article-title":"Can psychiatric childhood disorders be due to inborn errors of metabolism?","volume":"26","author":"Simons","year":"2017","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0930","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/j.1742-4658.2006.05202.x","article-title":"The narrow substrate specificity of human tyrosine aminotransferase--the enzyme deficient in tyrosinemia type II","volume":"273","author":"Sivaraman","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0935","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1056\/NEJMra044047","article-title":"Gamma-hydroxybutyric acid","volume":"352","author":"Snead","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0940","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1196\/annals.1444.011","article-title":"Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome","volume":"1142","author":"Sproule","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0945","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1590\/S0004-282X2007000200003","article-title":"Genotype and natural history in unrelated individuals with phenylketonuria and autistic behavior","volume":"65","author":"Steiner","year":"2007","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0950","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.brainresbull.2013.10.003","article-title":"A comparison of phenylketonuria with attention deficit hyperactivity disorder: do markedly different aetiologies deliver common phenotypes?","volume":"99","author":"Stevenson","year":"2013","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0955","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/1087054706288114","article-title":"Some abnormal psychical conditions in children: excerpts from three lectures","volume":"10","author":"Still","year":"2006","journal-title":"J. Atten. Disord."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0960","series-title":"Maple Syrup Urine Disease","author":"Strauss","year":"1993"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0965","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ymgme.2020.01.006","article-title":"Branched-chain alpha-ketoacid dehydrogenase deficiency (maple syrup urine disease): treatment, biomarkers, and outcomes","volume":"129","author":"Strauss","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0970","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1017\/S1461145701002462","article-title":"Analysis of neurosteroid levels in attention deficit hyperactivity disorder","volume":"4","author":"Strous","year":"2001","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0975","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1440-1819.2006.01515.x","article-title":"Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction","volume":"60","author":"Tanaka","year":"2006","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0980","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2016.11.013","article-title":"Impaired amino acid transport at the blood brain barrier is a cause of autism spectrum disorder","volume":"167","author":"Tarlungeanu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0985","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.phrs.2009.08.002","article-title":"Cellular ADMA: regulation and action","volume":"60","author":"Teerlink","year":"2009","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0990","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00702-014-1238-7","article-title":"Complex molecular regulation of tyrosine hydroxylase","volume":"121","author":"Tekin","year":"2014","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib0995","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ymgme.2010.11.003","article-title":"Increase of CSF tyrosine and impaired serotonin turnover in tyrosinemia type I","volume":"102","author":"Thimm","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib1000","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10545-011-9394-5","article-title":"Neurocognitive outcome in patients with hypertyrosinemia type I after long-term treatment with NTBC","volume":"35","author":"Thimm","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib1005","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1432-1033.1997.01180.x","article-title":"Participation of a stress-activated protein kinase cascade in the activation of tyrosine hydroxylase in chromaffin cells","volume":"247","author":"Thomas","year":"1997","journal-title":"Eur. J. Biochem."},{"issue":"Pt 1","key":"10.1016\/j.neubiorev.2021.11.012_bib1010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3470001","article-title":"Tetrahydrobiopterin biosynthesis, regeneration and functions","volume":"347","author":"Thony","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib1015","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1471-4159.2002.01172.x","article-title":"Regulation of tyrosine hydroxylase by stress-activated protein kinases","volume":"83","author":"Toska","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib1020","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.psyneuen.2012.12.002","article-title":"Biological mechanisms associated with increased perseveration and hyperactivity in a genetic mouse model of neurodevelopmental disorder","volume":"38","author":"Trent","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib1025","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.neuropharm.2009.07.026","article-title":"Neurobiology of ADHD","volume":"57","author":"Tripp","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib1030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/B978-0-12-804279-3.00002-2","article-title":"The cerebrospinal fluid and barriers - anatomic and physiologic considerations","volume":"146","author":"Tumani","year":"2017","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib1035","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1750-1172-6-43","article-title":"Cognitive development in patients with Mucopolysaccharidosis type III (Sanfilippo syndrome)","volume":"6","author":"Valstar","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib1040","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13023-016-0472-5","article-title":"Neurocognitive outcome in tyrosinemia type 1 patients compared to healthy controls","volume":"11","author":"van Ginkel","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib1045","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s40272-019-00364-4","article-title":"Long-term outcomes and practical considerations in the pharmacological management of tyrosinemia type 1","volume":"21","author":"van Ginkel","year":"2019","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib1050","first-page":"11","article-title":"The benefit of large neutral amino acid supplementation to a liberalized phenylalanine-restricted diet in adult phenylketonuria patients: evidence from adult Pah-Enu2 mice","author":"van Vliet","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib1055","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s13023-019-1259-2","article-title":"Emotional and behavioral problems, quality of life and metabolic control in NTBC-treated Tyrosinemia type 1 patients","volume":"14","author":"van Vliet","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib1060","doi-asserted-by":"crossref","first-page":"e1246","DOI":"10.1038\/tp.2017.209","article-title":"Genetically driven brain serotonin deficiency facilitates panic-like escape behavior in mice","volume":"7","author":"Waider","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib1065","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0006-2952(03)00556-2","article-title":"A unique central tryptophan hydroxylase isoform","volume":"66","author":"Walther","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib1070","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1126\/science.1078197","article-title":"Synthesis of serotonin by a second tryptophan hydroxylase isoform","volume":"299","author":"Walther","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib1075","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12881-019-0821-z","article-title":"Clinical diagnosis and mutation analysis of four Chinese families with succinic semialdehyde dehydrogenase deficiency","volume":"20","author":"Wang","year":"2019","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib1080","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.neures.2007.08.002","article-title":"The tryptophan hydroxylase 1 (TPH1) gene and risk of schizophrenia: a moderate-scale case-control study and meta-analysis","volume":"59","author":"Watanabe","year":"2007","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib1085","series-title":"Tyrosinemia Type 2","author":"Wendel","year":"2010"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib1090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112445","article-title":"Metabolomics as a tool for discovery of biomarkers of autism spectrum disorder in the blood plasma of children","volume":"9","author":"West","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib1095","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/apa.12169","article-title":"Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit\/hyperactivity disorder or autism spectrum disorder","volume":"102","author":"Wijburg","year":"2013","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib1100","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1172\/JCI110391","article-title":"Stratum corneum lipids in disorders of cornification: increased cholesterol sulfate content of stratum corneum in recessive x-linked ichthyosis","volume":"68","author":"Williams","year":"1981","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib1105","first-page":"21","article-title":"Brain branched-chain amino acids in maple syrup urine disease: implications for neurological disorders","author":"Xu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib1110","first-page":"7","article-title":"Long-term neurological outcomes of adult patients with phenylketonuria before and after newborn screening in Japan","author":"Yamada","year":"2021","journal-title":"Int. J. Neonatal Screen."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib1115","first-page":"591","article-title":"The modulatory role of dopamine in anxiety-like behavior","volume":"18","author":"Zarrindast","year":"2015","journal-title":"Arch. Iran. Med."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib1120","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1046\/j.1523-1747.1998.00386.x","article-title":"Recessive x-linked ichthyosis: role of cholesterol-sulfate accumulation in the barrier abnormality","volume":"111","author":"Zettersten","year":"1998","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib1125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2004.12.014","article-title":"Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression","volume":"45","author":"Zhang","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2021.11.012_bib1130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5582\/irdr.2020.01011","article-title":"A basic understanding of mucopolysaccharidosis: incidence, clinical features, diagnosis, and management","volume":"9","author":"Zhou","year":"2020","journal-title":"Intractable Rare Dis. Res."},{"key":"10.1016\/j.neubiorev.2021.11.012_bib1135","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1046\/j.0022-3042.2001.00710.x","article-title":"Reduced nitric oxide metabolites in CSF of patients with tetrahydrobiopterin deficiency","volume":"80","author":"Zorzi","year":"2002","journal-title":"J. Neurochem."}],"container-title":["Neuroscience & Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763421005054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763421005054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T23:29:28Z","timestamp":1720999768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763421005054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":227,"alternative-id":["S0149763421005054"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2021.11.012","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ADHD symptoms in neurometabolic diseases: Underlying mechanisms and clinical implications","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2021.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}